Find latest AML videos · 400+ videos
OncoPharm
J

Revumenib for KMT2A+ R/R Acute Leukemias - Drug Overview and Clinical Pearls

By OncoPharm FEATURING John Bossaer
By OncoPharm FEATURING John Bossaer
33 views
February 14, 2025
Comments 0
Login to view comments. Click here to Login

Featured Video

45:42
Amgen Sponsorship

FDA Approval for Frontline Consolidation in Patients with CD19-posit…

Feat. J. Mccloskey

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison

Related Videos

14:26

Year in Review 2024 - Transformative FDA Approvals in Precision Onco…

Oncology 2024 Year in Review

V. Subbiah

5.9K views
25:03

ASH 2024 Summary: Highlights in AML, MDS, and ALL

2024 ASH Annual Meeting Insights Hub

T. Badar

1.8K views
11:12
Stemline

A proven CD123 targeted therapy for BPDCN

Feat. H. Erba
23:28

Indy Hematology Review 2025: State of the Art 2025 - Emerging Therap…

Indy Hematology Review 2025

R. Birhiray

551 views
19:19

ASH 2024 Summary: Highlights in Adult ALL and Implications for Pract…

2024 ASH Annual Meeting Insights Hub

R. Cassaday

481 views
19:01

Debates in AML: 7+3 Is No Longer the Standard of Care

XV Eurasian Hematology-Oncology Congress - EHOC 2024

T. Kadia

1.3K views
12:55

ASH 2024 Summary: Menin Inhibitors in AML - FDA Approval and Highlig…

2024 ASH Annual Meeting Insights Hub

J. Zeidner

541 views
16:32

Indy Hematology Review 2025: Experts Debate the Treatment of ALL in …

Indy Hematology Review 2025

H. Kantarjian

245 views
19:26

Indy Hematology Review 2025: Treatment Options for Newly Diagnosed A…

Indy Hematology Review 2025

D. Pollyea

214 views
21:24

ASH 2024 Insights: Venetoclax + Aza for 1L Younger AML Pts Independe…

2024 ASH Annual Meeting Insights Hub

J. Watts

411 views
15:16

ASH 2024 Summary: Transplant Options and Outcomes for TP53 Myeloid D…

2024 ASH Annual Meeting Insights Hub

H. Fernandez

311 views
17:10

What’s New in AML: Treatment Advances and Key Trials in 2024

OncoAlert

F. Haddad

142 views
20:35

Indy Hematology Review 2025: Current and Emerging Therapies for Rela…

Indy Hematology Review 2025

R. Komrokji

129 views
26:58

Understanding the AML Disease State: Key Challenges and Advances

Cleveland Clinic Taussig Cancer Institute

M. Mustafa Ali

168 views
25:44

Myeloid Malignancies: Hot Topics in 2024

Yale Cancer Center

N. Podoltsev

462 views
07:10

Long-Term Follow-Up of the VIALE-A Study: Survival Outcomes and Subg…

Walter Fiedler

166 views
21:51

Experts Discuss the Pathophysiology, Diagnosis, and Treatment of BPD…

MyCancerHaven

R. Vij, G. Murthy

727 views
35:03

Advancements in AML Management in 2024

Louisville Hematology Highlights

C. Lachowiez

257 views
27:49

AML, MDS, and CML Highlights & Key Takeaways From ASCO®/EHA 2024

Insights from 2024 EHA Annual Meeting

T. Badar

857 views
07:32

ASH 2024 Summary: Highlights in Ph+ ALL

2024 ASH Annual Meeting Insights Hub

F. Haddad

152 views
AUTOPLAY